|
|
Article: FDA raises concerns about compounding.(RX RETAIL PHARMACY: Government)(Food and Drug Administration)
- Article from:
- Chain Drug Review
- Article date:
- February 4, 2008
CopyrightCOPYRIGHT 2008 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- In a series of warning letters to compounding pharmacies across the country, the Food and Drug Administration has asserted a policy that the International Academy of Compounding Pharmacists (IACP) charges would deny hundreds of thousands of women access to many compounded bioidentical hormones.
Hormone replacement is prescribed to relieve hot flashes and other symptoms resulting from the loss of estrogen in women who are undergoing menopause.
"The FDA is concerned that the claims for safety, effectiveness and superiority that these pharmacy operations are making may mislead patients as well as doctors and other health care professionals," ...